DAPK2 was identified and validated as a critical biomarker associated with the immune disorder and granulosa cell dysfunction in PCOS with hyperandrogenism, acting as an independent predictor of embryo implantation failure. The gene discussed is DAPK2; the disease is polycystic ovary syndrome.